National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -7 of 7         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Completed


18 and over


Pharmaceutical / Industry


CLBH589B2211
NCT00449761


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Completed


18 and over


Pharmaceutical / Industry


CLBH589B2202
NCT00451035


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Closed


20 and over


Pharmaceutical / Industry


CLBH589B1101
NCT00412997


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Closed


18 and over


Pharmaceutical / Industry


CLBH589B2108
NCT00472368


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Closed


18 and over


Pharmaceutical / Industry


CLBH589B2110
NCT00503451


6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Temporarily closed


18 and over


Other


SCRI REFMAL 121
NCT00556088


7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Closed


18 and over


Pharmaceutical / Industry


CLBH589B2111
NCT00570284

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov